The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

Novavax, Inc. faces profitability challenges despite a promising tech platform, with uncertain revenue streams. Click for my ...

BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...

German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion worth of BioNTech shares, it ...

Valued at $1.25 billion, the deal expands BioNTech’s cancer drug portfolio and heads off royalty costs it could have owed ...

CureVac shares skyrocketed 35% Thursday when the biotech firm agreed to be bought by COVID-19 vaccine maker BioNTech in an all-stock deal valued at about $1.25 billion.

BioNTech said Thursday it has agreed to acquire smaller biotech CureVac in a $1.25 billion all-stock deal in another push to ...

Through Friday, Capital One’s COF stock had returned 10.9% for 2025, while Discover shares had returned 16% as investors became more confident the deal would be completed. The KBW Bank Index had ...

Covid vaccine sales totaled $1.8 billion for the third quarter. That blew past analysts’ estimates of $1.2 billion, and was slightly higher than a year earlier. Moderna's stock rose nearly 1.5% ...

In other words, the U.S. coronavirus vaccine market just became smaller ... It's not time to give up on the stock just yet, even with the recent regulatory changes in the U.S. Pfizer could ...

READ ALSO: 10 AI Stocks on Wall Street’s Radar and 12 AI Stocks on Latest News and Ratings. The company has acknowledged that the AI model was capable of “extreme actions” if it thought ...

The EU has secured 450 million doses of bird flu vaccines from multiple manufacturers, including CSL Seqirus - Simon Townsley ...